Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nam H Dang

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
The Journal of Rheumatology|September 6, 2005
Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophagesYasuyo Urasaki, Mamoru Nori, Satoshi Iwata, et al.
Diagnostic Pathology|February 8, 2014
Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissueRyo Hatano, Taketo Yamada, Shuji Matsuoka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrixTeruo Inamoto, Tadanori Yamochi, Kei Ohnuma, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2004
CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1Kei Ohnuma, Tadanori Yamochi, Masahiko Uchiyama, et al.
Immunology|November 9, 2002
G1/S cell cycle arrest provoked in human T cells by antibody to CD26Kei Ohnuma, Tomonori Ishii, Satoshi Iwata, et al.
Frontiers in Bioscience (Landmark Edition)|May 18, 2018
A novel role for CD26/dipeptidyl peptidase IV as a therapeutic targetKei Ohnuma, Ryo Hatano, Eriko Komiya, et al.
Molecular and Clinical Oncology|January 19, 2019
A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancersAzka Ali, Alejandra Fuentes, William Paul Skelton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2003
SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 productionTomonori Ishii, Kei Ohnuma, Akikazu Murakami, et al.
Molecular and Cellular Biology|August 19, 2005
CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cellsKei Ohnuma, Tadanori Yamochi, Masahiko Uchiyama, et al.
Biochemical and Biophysical Research Communications|March 12, 2009
SHP-2 inhibits tyrosine phosphorylation of Cas-L and regulates cell migrationKoji Yo, Satoshi Iwata, Yutaka Hashizume, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Rheumatology|September 6, 2005
Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophagesYasuyo Urasaki, Mamoru Nori, Satoshi Iwata, et al.
Diagnostic Pathology|February 8, 2014
Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissueRyo Hatano, Taketo Yamada, Shuji Matsuoka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrixTeruo Inamoto, Tadanori Yamochi, Kei Ohnuma, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2004
CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1Kei Ohnuma, Tadanori Yamochi, Masahiko Uchiyama, et al.
Immunology|November 9, 2002
G1/S cell cycle arrest provoked in human T cells by antibody to CD26Kei Ohnuma, Tomonori Ishii, Satoshi Iwata, et al.
Frontiers in Bioscience (Landmark Edition)|May 18, 2018
A novel role for CD26/dipeptidyl peptidase IV as a therapeutic targetKei Ohnuma, Ryo Hatano, Eriko Komiya, et al.
Molecular and Clinical Oncology|January 19, 2019
A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancersAzka Ali, Alejandra Fuentes, William Paul Skelton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2003
SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 productionTomonori Ishii, Kei Ohnuma, Akikazu Murakami, et al.
Molecular and Cellular Biology|August 19, 2005
CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cellsKei Ohnuma, Tadanori Yamochi, Masahiko Uchiyama, et al.
Biochemical and Biophysical Research Communications|March 12, 2009
SHP-2 inhibits tyrosine phosphorylation of Cas-L and regulates cell migrationKoji Yo, Satoshi Iwata, Yutaka Hashizume, et al.
Pageof 13